Drug Trial Radar · NCT07768371
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
576
Planned (sponsor's estimate)
Start
Aug 27, 2026
Primary completion
Mar 30, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Aug 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase III study is to evaluate the clinical efficacy and safety of remibrutinib in participants with peanut, or cow's milk ("milk", cooked and uncooked) or hen's egg ("egg", cooked and uncooked) immunoglobulin E (IgE)- mediated allergy in comparison to placebo.
Conditions
- IgE-Mediated Food Allergy
- Peanut Allergy
- Cow Milk Allergy
- Egg Allergy
Interventions
RemibrutinibDrug
Oral administration of remibrutinib.
PlaceboDrug
Oral administration of placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sub-study 1: Number of participants achieving response status (tolerated at least 600 mg of peanut protein)Time frame: Week 24
- Sub-study 2: Number of participants achieving response status (tolerated at least 1000 mg of milk protein)Time frame: Week 24
- Sub-study 3: Number of participants achieving response status (tolerated at least 1000 mg of egg protein)Time frame: Week 24
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
AllerVie Clinical Research-Homewood
Birmingham, Alabama · Recruiting
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Medical Resch of Arizona-Div of Allergy Asthma and Immunology
Scottsdale, Arizona · Recruiting
Arkansas Childrens Hosp Rsch Inst
Little Rock, Arkansas · Recruiting
California Allergy and Asthma Medical Group
Los Angeles, California · Recruiting
Stanford Univ Sean N Parker Center for Allergy and Asthma Re
Palo Alto, California · Recruiting
Asthma and Allergy Associates P C
Colorado Springs, Colorado · Recruiting
Childrens Healthcare Of Atlanta
Atlanta, Georgia · Recruiting
Sneeze Wheeze Itch Asso LLC
Normal, Illinois · Recruiting
Asthma and Allergy Center of Chicago S C
River Forest, Illinois · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Institute for Asthma and Allergy PC
Chevy Chase, Maryland · Recruiting
Boston Childrens Hospital
Boston, Massachusetts · Recruiting
Respiratory Medicine Research Institute of Michigan
Ypsilanti, Michigan · Recruiting
Impact Medical - Circuit Clinical
Riverdale, New Jersey · Recruiting
Northwell Health
New York, New York · Recruiting
Montefiore Health System
The Bronx, New York · Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
National Allergy and Asthma Research LLS
North Charleston, South Carolina · Recruiting
Western Sky Medical Research
El Paso, Texas · Recruiting
Allergy Associates of Utah
Sandy City, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.